Invent Medic Sweden ABXSAT:IMS -6.82%36 Days Payable is 228.55 as of Mar. 2026, which is 37% below its 10-year median of 363.62. GuruFocus rates XSAT:IMS with a GF Score™ of 36/100 and a GF Value™ of kr0.18 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Invent Medic Sweden AB ranks better than 85.28% on this metric.
The historical rank and industry rank for Invent Medic Sweden AB's Days Payable or its related term are showing as below:
XSAT:IMS'
s Days Payable Range Over the Past 10 Years
Min: 110.72 Med: 363.62 Max: 1225.53
Current: 209.72
During the past 10 years, Invent Medic Sweden AB's highest Days Payable was 1225.53. The lowest was 110.72. And the median was 363.62.
XSAT:IMS's Days Payable is ranked better than 85.28% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs XSAT:IMS: 209.72
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:IMS vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Invent Medic Sweden AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Invent Medic Sweden AB Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Invent Medic Sweden AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Invent Medic Sweden AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Invent Medic Sweden AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invent Medic Sweden AB (XSAT:IMS) has a Days Payable of 228.55 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Invent Medic Sweden AB and its competitors. This is 37% below median its historical median of 363.62. Over the past decade, Invent Medic Sweden AB's Days Payable has ranged from 110.72 to 1,225.53. According to the industry distribution chart, Invent Medic Sweden AB ranks #117 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 14.7%.
Is Invent Medic Sweden AB's Days Payable too high?
Invent Medic Sweden AB's current Days Payable of 228.55 is 37% below median its 10-year median of 363.62. Over the past 10 years, this metric has ranged from a low of 110.72 to a high of 1,225.53. The Medical Devices & Instruments industry median Days Payable is 68.07. Invent Medic Sweden AB's value of 228.55 is 235.8% above this industry median. Based on the distribution chart, Invent Medic Sweden AB ranks #117 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Invent Medic Sweden AB has a GF Score™ of 36/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Invent Medic Sweden AB's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Invent Medic Sweden AB ranks #117 out of 795 companies for Days Payable. This places Invent Medic Sweden AB in the top 15% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.07. Invent Medic Sweden AB's value of 228.55 is 235.8% above this benchmark. Historically, Invent Medic Sweden AB's own Days Payable has ranged from 110.72 to 1,225.53 over the past decade. While the company's 10-year median is 363.62 vs. the industry median of 68.07, Invent Medic Sweden AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Invent Medic Sweden AB's current Days Payable of 228.55 is 235.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Invent Medic Sweden AB and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Invent Medic Sweden AB's current Days Payable is 228.55, which is 37% below median its own 10-year median of 363.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invent Medic Sweden AB stock overvalued right now?
Based on GuruFocus' analysis, Invent Medic Sweden AB (XSAT:IMS) is currently considered Significantly Undervalued. The stock's GF Value™ is kr0.18, compared to a current price of kr0.12 — trading 31.7% below its estimated fair value. The current Days Payable is 228.55, which is 37% below median its 10-year median of 363.62 and 235.8% above the Medical Devices & Instruments industry median of 68.07. Invent Medic Sweden AB's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Invent Medic Sweden AB (XSAT:IMS), the current Days Payable is 228.55 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Invent Medic Sweden AB (XSAT:IMS) Overvalued in 2026?
Based on GuruFocus' analysis, Invent Medic Sweden AB stock appears to be undervalued.
The current stock price of kr0.12 is trading 31.7% below its estimated GF Value™ of kr0.18.
GuruFocus considers Invent Medic Sweden AB to be Significantly Undervalued.
Key valuation signals for XSAT:IMS:
Days Payable: 228.55 (37% below median its 10-year median of 363.62)
GF Value™: kr0.18 vs. price of kr0.12 (31.7% below fair value)
Industry Position: 235.8% above the Medical Devices & Instruments median (#117 of 795)
No single metric tells the full story. See the XSAT:IMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Invent Medic Sweden AB develops and markets its product - Efemia bladder support, a vaginal medical device for the treatment of female urinary incontinence.
36GF Score
Get the complete analysis for XSAT:IMS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:IMS has been successfully added to your 
